These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31686096)

  • 21. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
    Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
    Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia.
    Liu-Seifert H; Siemers E; Sundell K; Price K; Han B; Selzler K; Aisen P; Cummings J; Raskin J; Mohs R
    J Alzheimers Dis; 2015; 43(3):949-55. PubMed ID: 25125457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.
    Yatawara C; Lim L; Chander R; Zhou J; Kandiah N
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference in determinants of caregiver burden between amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ikeda C; Terada S; Oshima E; Hayashi S; Okahisa Y; Takaki M; Inagaki M; Yokota O; Uchitomi Y
    Psychiatry Res; 2015 Mar; 226(1):242-6. PubMed ID: 25631688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab.
    Fillit H; Seleri Assunção S; Majda T; Ng CD; To TM; Abbass IM; Raimundo K; Wallick C; Tcheremissine OV
    J Prev Alzheimers Dis; 2024; 11(5):1251-1259. PubMed ID: 39350370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
    Vellas B; Carrillo MC; Sampaio C; Brashear HR; Siemers E; Hampel H; Schneider LS; Weiner M; Doody R; Khachaturian Z; Cedarbaum J; Grundman M; Broich K; Giacobini E; Dubois B; Sperling R; Wilcock GK; Fox N; Scheltens P; Touchon J; Hendrix S; Andrieu S; Aisen P;
    Alzheimers Dement; 2013 Jul; 9(4):438-44. PubMed ID: 23809364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making sense of self in Alzheimer's disease: reflective function and memory.
    Simm LA; Jamieson RD; Ong B; Garner MWJ; Kinsella GJ
    Aging Ment Health; 2017 May; 21(5):501-508. PubMed ID: 26666687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subjective rating of executive functions in mild Alzheimer's disease.
    Fogarty J; Almklov E; Borrie M; Wells J; Roth RM
    Aging Ment Health; 2017 Nov; 21(11):1184-1191. PubMed ID: 27454406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aducanumab for Alzheimer's Disease: Summarized Data From EMERGE, ENGAGE, and PRIME Studies.
    Yuksel JM; Noviasky J; Britton S
    Sr Care Pharm; 2022 Aug; 37(8):329-334. PubMed ID: 35879846
    [No Abstract]   [Full Text] [Related]  

  • 32. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    Hird MA; Egeto P; Fischer CE; Naglie G; Schweizer TA
    J Alzheimers Dis; 2016 May; 53(2):713-29. PubMed ID: 27176076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the effect of cognitive/brain reserve and depression on regional atrophy in early Alzheimer's disease.
    Capogna E; Manca R; De Marco M; Hall A; Soininen H; Venneri A
    Postgrad Med; 2019 Sep; 131(7):533-538. PubMed ID: 31478419
    [No Abstract]   [Full Text] [Related]  

  • 34. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease.
    Senturk G; Bilgic B; Arslan AB; Bayram A; Hanagasi H; Gurvit H; Emre M
    Int Psychogeriatr; 2017 Feb; 29(2):293-302. PubMed ID: 27780496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients.
    Wams EJ; Wilcock GK; Foster RG; Wulff K
    Curr Alzheimer Res; 2017; 14(10):1030-1041. PubMed ID: 28545363
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
    Putcha D; Tremont G
    J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
    Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
    J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease.
    Tangen GG; Engedal K; Bergland A; Moger TA; Hansson O; Mengshoel AM
    Int Psychogeriatr; 2015 Aug; 27(8):1401-9. PubMed ID: 25644091
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.